Prognostic (18)F-flotufolastat PET parameters for outcome assessment of (177)Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer
转移性去势抵抗性前列腺癌中,(18)F-flotufolastat PET参数用于评估(177)Lu标记的PSMA靶向放射性配体治疗的疗效
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-07003-2
Karimzadeh, Amir; Hansen, Kimberley; Hasa, Ergela; Haller, Bernhard; Heck, Matthias M; Tauber, Robert; D Alessandria, Calogero; Weber, Wolfgang A; Eiber, Matthias; Rauscher, Isabel